Your Source for Venture Capital and Private Equity Financings

Reservoir Neuroscience Nabs $4M

2024-01-18
SAN FRANCISCO, CA, Reservoir Neuroscience announced today the completion of a $4 million financing round to support the development of new therapies for age-related neurodegeneration.
Reservoir will use the funds to develop its novel class of drug compounds designed to restore health to the brain's blood vessels to rejuvenate the aging brain. The round was led by Kizoo Technology Capital, a leading rejuvenation biotech investor focused on startups reversing age-related damage at the cellular and molecular level, with additional participation from previous investors R42 Fund and Healthspan Ventures.

Reservoir Neuroscience is a biotech company advancing a novel therapy to reverse brain vascular pathology in aging and neurodegenerative diseases. In these critically unmet diseases, the brain's blood vessels become damaged and dysfunctional; causing inflammation that drives disease outcomes. This vascular pathology is the earliest biomarker of neurodegeneration and defines the largest patient segment yet has never been treated.Reservoir Neuroscience developed a proprietary human organ chip platform to discover novel, class-leading compounds that restore brain vascular health, offering a first-in-kind approach to reverse vascular pathology and neuroinflammation.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors